It’s not a surprise that 4 of the top 20 drugs in worldwide sales in 2021 were COVID-related medications. Pfizer and BioNTech’s vaccine topped the list generating $36.8 billion in sales. Other notable movers were Dupixent (Regeneron and Sanofi’s eczema treatment) with a 55% increase in sales, Darzalex (Johnson and Johnson’s cancer treatment) had a 43% increase in sales and Trikafta (Vertex’s cystic fibrosis drug) had a 46 % increase in sales.

AES Clean Technology is celebrating! The provider of high-performance cleanroom facilities within the pharmaceutical and biopharmaceutical industry has just received news that they produced three of this year’s winners for Facility of the Year by The International Society for Pharmaceutical Engineering (ISPE). This means AES was a cleanroom partner to all of the North American award-winning and honorable mention facilities.

Jorge Gomez, former CFO at Moderna was let go after one day on the job and will need to return his $700,000 severance pay if he is found guilty of wrongdoing with his former employer.

ADC Therapeutics has announced that co-founder Chris Martin is stepping away from his role as CEO of the commercial-stage biotechnology company. Joining the company is Ameet Mallik, formerly Head of Oncology at Novartis and CEO of Rafel Holdings.

Over the upcoming weeks, the Fierce Biotech and Fierce Pharma teams will profile influential CEOs scientists, entrepreneurs, and regulatory experts in the biopharma world.

Viatrus, formerly Mylan Pharmaceuticals has sold its former manufacturing plant in Morgantown, West Virginia to West Virginia University for $1. The former factory, which once housed more than 1,400 employees and was closed last summer.

Data analytics can have a profound effect on how a business operates, and they play a large role in the growth strategies that businesses employ. Currently, only about 50% of businesses are making use of data analytics, but that number will only continue to grow in today's technology-driven society. Here are just a few of the benefits your business can expect to see once you begin making data analytics part of your business operations.

Less than three years after launching its breast cancer drug Piqray, Novartis has received an FDA approval for the treatment in a rare condition PROS. This drug, named Vijoice, a PI3K inhibitor to treat PIK3CA-related overgrowth spectrum (PROS), an umbrella term for the rare condition that causes blood vessel abnormalities and overgrowth of tissue that can present in a variety of ways.

Data thieves can use SMS messages to steal your personal information. Watch out for these warning signs.

According to the Pew Research Center, 21 percent of Americans say they regularly wear smartwatches or fitness trackers. As companies look to save money whether it is preventing workplace injuries or cutting insurance costs by employees making healthier lifestyle changes they are investigating the possibilities of how wearable devices can be used in the workplace.

On Monday, Pfizer issued a voluntary recall of its blood pressure drug Accuretic along with two of its generic hypertension treatments distributed by Greenstone in the United States because of the presence of cancer-causing agents. Earlier in the month, they recalled two of its blood pressure medicines in Canada.

In a new national Cologuard, Katie Couric talks about losing her first husband, Jay Monahan to colon cancer at the age of 42 in an effort to encourage people age 45 or older to get screened for colon cancer.

Employee benefits are programs or activities that extend beyond your team members' pay. This typically includes health insurance and paid time off at a minimum, as well as retirement matching, dental and vision insurance and life insurance. Perhaps you even offer extra perks like catered lunches and casual Fridays. While all of this is great, in order to attract top talent and to encourage loyalty and hard work from your current staff, it’s crucial to refresh your offerings. Not only will you help increase employee morale, but you’ll become a more competitive employer. It’s a win-win!

Positive Phase 3 data of Sanofi’s Dupixant has the company submitting data to the FDA for a fourth approval for the medication. According to Sanofi’s CFO, Jean-Baptiste Chasseloup de Chatillon the company’s plan to build Big Pharma’s “strongest franchise in immunology” hinges on their lead product Dupixent.

The FDA has approved Agios' first-in-class Pyrukynd. This oral medication is the first FDA-approved medicine for the rare and debilitating blood disorder, hemolytic anemia in adults with pyruvate kinase (PK) deficiency.

Starting a business is a journey. Sure, there will be some ups and downs along the way. And even a few mistakes here and there as you test ways that work for you and discover ways that don't. However, there are certain common pitfalls that many entrepreneurs have fallen into the trap of doing, sometimes without even knowing it. See below how to identify them and how you can avoid them.

In preparation for a potential Alzheimer’s launch, Eli Lilly is investing more than $440 million into a facility in Limerick, Ireland. The plant will employ more than 300 people once built. Additionally, they will spend $1 billion on an injectables facility in Concord, NC. This plant will hold some 600 workers. The site is about 400 acres, which will allow for future growth. Construction will start this year 2022 and take several years to complete.

​According to recent studies, only around eight percent of high-potential individuals succeed. The rest derail. This metaphor is that of a train coming off the tracks, and it involves an unexpected stall on a person's career path. It can happen when a leader plateaus in their current role due to significant weaknesses. If not corrected, these flaws can become fatal setbacks, eventually dragging a leader down completely.

Education is a valuable thing. Most jobs that you’ll look at applying to recommend having at least a bachelor’s these days, with plenty of others preferring a master’s. Thankfully, there are online universities that allow people to take a more flexible approach to their schooling. Are you considering attending an online university? We’re going to cover everything you need to know to help you make your decision in this article.

In its mission to deliver 20 new drugs to the market in a decade, Eli Lilly is looking forward to two new launches in 2022. One is donanemab, a new treatment for Alzheimer’s disease. They have submitted the drug for an accelerated approval and expects to complete its rolling submission by the end of Q1 in 2022 with the hopes of a launch by the end of the year.